| [1] |
Hamblin PS， Russell AW， Talic S，et al.The growing range of complications of diabetes mellitus[J]. Trends Endocrinol Metab， 2025， 36(10)：943-954.DOI： 10.1016/j.tem.2024.12.006.
|
| [2] |
Młynarska E， Czarnik W， Dziez·a N，et al.Type 2 diabetes mellitus：new pathogenetic mechanisms，treatment and the most important complications[J]. Int J Mol Sci， 2025， 26(3)：1094.DOI： 10.3390/ijms26031094.
|
| [3] |
|
| [4] |
Stalder T, Oster H, Abelson JL, et al. The cortisol awakening response：regulation and functional significance[J]. Endocr Rev， 2025， 46(1)：43-59.DOI： 10.1210/endrev/bnae024.
|
| [5] |
Lightman SL， Birnie MT， Conway-Campbell BL.Dynamics of ACTH and cortisol secretion and implications for disease[J]. Endocr Rev， 2020， 41(3)：bnaa002.DOI： 10.1210/endrev/bnaa002.
|
| [6] |
Gan L， Li N， Heizhati M，et al.Diurnal cortisol features and type 2 diabetes risk in patients with hypertension and obstructive sleep apnea：a cohort study[J]. J Clin Endocrinol Metab， 2023， 108(9)：e679-e686.DOI： 10.1210/clinem/dgad184.
|
| [7] |
Hackett RA， Kivimäki M， Kumari M，et al.Diurnal cortisol patterns，future diabetes，and impaired glucose metabolism in the Whitehall II cohort study[J]. J Clin Endocrinol Metab， 2016， 101(2)：619-625.DOI： 10.1210/jc.2015-2853.
|
| [8] |
Ortiz R， Kluwe B， Odei JB，et al.The association of morning serum cortisol with glucose metabolism and diabetes：the Jackson Heart Study[J]. Psychoneuroendocrinology， 2019(103)：25-32.DOI： 10.1016/j.psyneuen.2018.12.237.
|
| [9] |
Hackett RA， Steptoe A， Kumari M．Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study[J]. J Clin Endocrinol Metab， 2014， 99(12)：4625-4631.DOI： 10.1210/jc.2014-2459.
|
| [10] |
Buse JB， Kahn SE， Aroda VR，et al.Prevalence of hypercortisolism in difficult-to-control type 2 diabetes[J]. Diabetes Care， 2025， 48(12)：2012-2020.DOI： 10.2337/dc24-2841.
|
| [11] |
Defronzo RA.Banting Lecture.From the triumvirate to the ominous octet：a new paradigm for the treatment of type 2 diabetes mellitus[J]. Diabetes， 2009， 58(4)：773-795.DOI： 10.2337/db09-9028.
|
| [12] |
DeFronzo RA， Auchus RJ.Cushing syndrome，hypercortisolism，and glucose homeostasis：a review[J]. Diabetes， 2025， 74(12)：2168-2178.DOI： 10.2337/db25-0120.
|
| [13] |
Brosolo G, Da PortoA, Bulfone L, et al. Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension[J]. J Hypertens， 2024， 42(2)：227-235.DOI： 10.1097/HJH.0000000000003590.
|
| [14] |
Brox-Torrecilla N， García CanoAM， Valderrábano P，et al.Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas：a study of 709 cases[J]. Endocrine， 2023， 81(3)：484-491.DOI： 10.1007/s12020-023-03396-6.
|
| [15] |
Elhassan YS， Alahdab F， Prete A，et al.Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess：a systematic review and meta-analysis[J]. Ann Intern Med， 2019， 171(2)：107-116.DOI： 10.7326/M18-3630.
|
| [16] |
Kluwe B， Ortiz R， Odei JB，et al.The association of cortisol curve features with incident diabetes among whites and African Americans：the CARDIA study[J]. Psychoneuroendocrinology， 2021(123)：105041.DOI： 10.1016/j.psyneuen.2020.105041.
|
| [17] |
Seaton EK， Zeiders KH.Daily racial discrimination experiences，ethnic-racial identity，and diurnal cortisol patterns among Black adults[J]. Cultur Divers Ethnic Minor Psychol， 2021， 27(1)：145-155.DOI： 10.1037/cdp0000367.
|
| [18] |
Song M, Bai H, Zhang P, et al. Promising applications of human-derived saliva biomarker testing in clinical diagnostics[J]. Int J Oral Sci， 2023， 15(1)：2.DOI： 10.1038/s41368-022-00209-w.
|
| [19] |
Lederbogen F， Hummel J， Fademrecht C，et al.Flattened circadian cortisol rhythm in type 2 diabetes[J]. Exp Clin Endocrinol Diabetes， 2011， 119(9)：573-575.DOI： 10.1055/s-0031-1275288.
|
| [20] |
Johar H， Emeny RT， Bidlingmaier M，et al.Sex-related differences in the association of salivary cortisol levels and type 2 diabetes.Findings from the cross-sectional population based KORA-age study[J]. Psychoneuroendocrinology， 2016(69)：133-141.DOI： 10.1016/j.psyneuen.2016.04.004.
|
| [21] |
Champaneri S， Xu X， Carnethon MR，et al.Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus：the Multi-Ethnic Study of Atherosclerosis[J]. Metabolism， 2012， 61(7)：986-995.DOI： 10.1016/j.metabol.2011.11.006.
|
| [22] |
王怡丹.2型糖尿病患者皮质醇节律异常的相关因素分析[D].大连：大连医科大学，2020.
|
| [23] |
Incollingo RodriguezAC， Epel ES， White ML，et al.Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity：a systematic review[J]. Psychoneuroendocrinology， 2015(62)：301-318.DOI： 10.1016/j.psyneuen.2015.08.014.
|
| [24] |
Spanakis EK， Wang X， Sánchez BN，et al.Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol：the multiethnic study of atherosclerosis[J]. Endocrine， 2016， 53(1)：227-239.DOI： 10.1007/s12020-016-0887-8.
|
| [25] |
Liang Y， Liang J， Jiang W，et al.Stronger association between morning serum cortisol level and diurnal time in range in type 2 diabetes？[J]. Diabetol Metab Syndr， 2024， 16(1)：290.DOI： 10.1186/s13098-024-01515-5.
|
| [26] |
Mohd AzmiN， Juliana N， Azmani S，et al.Cortisol on circadian rhythm and its effect on cardiovascular system[J]. Int J Environ Res Public Health， 2021， 18(2).DOI： 10.3390/ijerph18020676.
|
| [27] |
Boudreau P， Yeh WH， Dumont GA，et al.Circadian variation of heart rate variability across sleep stages[J]. Sleep， 2013， 36(12)：1919-1928.DOI： 10.5665/sleep.3230.
|
| [28] |
Karl S， Johar H， Ladwig KH，et al.Dysregulated diurnal cortisol patterns are associated with cardiovascular mortality：findings from the KORA-F3 study[J]. Psychoneuroendocrinology， 2022(141)：105753.DOI： 10.1016/j.psyneuen.2022.105753.
|
| [29] |
Reynolds RM， Labad J， Strachan MW，et al.Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes：the Edinburgh type 2 diabetes study[J]. J Clin Endocrinol Metab， 2010， 95(4)：1602-1608.DOI： 10.1210/jc.2009-2112.
|
| [30] |
Jin Y， Wei D， Liu P，et al.Serum cortisol，25 (OH)D，and cardiovascular risk factors in patients with type 2 diabetes mellitus[J]. Int J Endocrinol， 2022(2022)：5680170.DOI： 10.1155/2022/5680170.
|
| [31] |
Chiodini I， Adda G， Scillitani A，et al.Cortisol secretion in patients with type 2 diabetes：relationship with chronic complications[J]. Diabetes Care， 2007， 30(1)：83-88.DOI： 10.2337/dc06-1267.
|
| [32] |
Sun S， Wang Y．Relationship between cortisol and diabetic microvascular complications：a retrospective study[J]. Eur J Med Res， 2023， 28(1)：391.DOI： 10.1186/s40001-023-01325-x.
|
| [33] |
Zhang X， Deng X， Zhou J，et al.The association of serum cortisol level with microalbuminuria in patients with type 2 diabetes and prediabetes[J]. Int J Med Sci， 2020， 17(18)：2998-3004.DOI： 10.7150/ijms.48742.
|
| [34] |
Li S， Luo X， Lu Z，et al.Association of midnight cortisol level with bone mineral density in Chinese patients with type 2 diabetes mellitus：a cross-sectional study[J]. Diabetes Metab Syndr Obes， 2024(17)：2943-2953.DOI： 10.2147/DMSO.S470391.
|
| [35] |
Liu F, Yang Q, Yang K, et al. Cortisol circadian rhythm and sarcopenia in patients with type 2 diabetes：a cross-sectional study[J]. J Cachexia Sarcopenia Muscle， 2025， 16(1)：e13727.DOI： 10.1002/jcsm.13727.
|
| [36] |
Isidori AM， Pofi R， Fleseriu M．Beyond the classical axis：metabolic " pressure" on the adrenal gland？[J]. Diabetes， 2025， 74(12)：2207-2210.DOI： 10.2337/dbi25-0035.
|
| [37] |
Clarke SA, Eng PC, Comninos AN, et al. Current challenges and future directions in the assessment of glucocorticoid status[J]. Endocr Rev， 2024， 45(6)：795-817.DOI： 10.1210/endrev/bnae016.
|
| [38] |
Tanoue A， Ito S， Honda K，et al.The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions[J]. J Clin Invest， 2004， 113(2)：302-309.DOI： 10.1172/JCI19656.
|
| [39] |
Gathercole LL， Lavery GG， Morgan SA，et al.11β-hydroxysteroid dehydrogenase 1：translational and therapeutic aspects[J]. Endocr Rev， 2013， 34(4)：525-555.DOI： 10.1210/er.2012-1050.
|
| [40] |
Dendoncker K， Timmermans S， Vandewalle J，et al.TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile[J]. Proc Natl Acad Sci U S A， 2019， 116(26)：12942-12951.DOI： 10.1073/pnas.1821565116.
|
| [41] |
Andreadi A， Andreadi S， Todaro F，et al.Modified cortisol circadian rhythm：the hidden toll of night-shift work[J]. Int J Mol Sci， 2025， 26(5)：2090.DOI： 10.3390/ijms26052090.
|
| [42] |
Kim N， Ka S， Park J．Effects of exercise timing and intensity on physiological circadian rhythm and sleep quality：a systematic review[J]. Phys Act Nutr， 2023， 27(3)：52-63.DOI： 10.20463/pan.2023.0029.
|
| [43] |
Paragliola RM, Marchetti M, Montagna C, et al. " Feeding the rhythm" -effects of food and nutrients on daily cortisol secretion：from molecular mechanisms to clinical impact[J]. Int J Mol Sci， 2025， 26(22)：11230.DOI： 10.3390/ijms262211230.
|
| [44] |
Rogerson O， Wilding S， Prudenzi A，et al.Effectiveness of stress management interventions to change cortisol levels：a systematic review and meta-analysis[J]. Psychoneuroendocrinology， 2024(159)：106415.DOI： 10.1016/j.psyneuen.2023.106415.
|
| [45] |
Luo C， Yu XM， Zeng MQ，et al.Breaking the diabetes-depression cycle：exploring shared mechanisms，neuroinflammation，and emerging interventions for metabolic-mood comorbidities[J]. World J Diabetes， 2025， 16(7)：107406.DOI： 10.4239/wjd.v16.i7.107406.
|
| [46] |
Rosenstock J， Banarer S， Fonseca VA，et al.The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy[J]. Diabetes Care， 2010， 33(7)：1516-1522.DOI： 10.2337/dc09-2315.
|
| [47] |
DeFronzo RA， Fonseca V， Aroda VR，et al.Inadequately controlled type 2 diabetes and hypercortisolism：improved glycemia with mifepristone treatment[J]. Diabetes Care， 2025， 48(12)：2036-2044.DOI： 10.2337/dc25-1055.
|